BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 18223356)

  • 21. The convergent development of molecular-targeted drugs for cancer treatment and prevention.
    Lippman SM; Heymach JV
    Clin Cancer Res; 2007 Jul; 13(14):4035-41. PubMed ID: 17634526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The chemopreventive agent development research program in the Division of Cancer Prevention of the US National Cancer Institute: an overview.
    Crowell JA
    Eur J Cancer; 2005 Sep; 41(13):1889-910. PubMed ID: 16005206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of genistein aglycone on cancer and cancer risk: a review of in vitro, preclinical, and clinical studies.
    Taylor CK; Levy RM; Elliott JC; Burnett BP
    Nutr Rev; 2009 Jul; 67(7):398-415. PubMed ID: 19566600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lycopene: features and potential significance in the oral cancer and precancerous lesions.
    Lu R; Dan H; Wu R; Meng W; Liu N; Jin X; Zhou M; Zeng X; Zhou G; Chen Q
    J Oral Pathol Med; 2011 May; 40(5):361-8. PubMed ID: 21198870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticancer properties of carotenoids in prostate cancer. A review.
    Soares Nda C; Teodoro AJ; Lotsch PF; Granjeiro JM; Borojevic R
    Histol Histopathol; 2015 Oct; 30(10):1143-54. PubMed ID: 26058846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinoids and carotenoids in the prevention of oral cancer: a critical appraisal.
    Garewal HS; Meyskens F
    Cancer Epidemiol Biomarkers Prev; 1992; 1(2):155-9. PubMed ID: 1306099
    [No Abstract]   [Full Text] [Related]  

  • 27. Modulation of aflatoxin toxicity and biomarkers by lycopene in F344 rats.
    Tang L; Guan H; Ding X; Wang JS
    Toxicol Appl Pharmacol; 2007 Feb; 219(1):10-7. PubMed ID: 17229449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A mechanistic updated overview on lycopene as potential anticancer agent.
    Ozkan G; Günal-Köroğlu D; Karadag A; Capanoglu E; Cardoso SM; Al-Omari B; Calina D; Sharifi-Rad J; Cho WC
    Biomed Pharmacother; 2023 May; 161():114428. PubMed ID: 36841029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Functional properties and health benefits of lycopene].
    Cruz Bojórquez RM; González Gallego J; Sánchez Collado P
    Nutr Hosp; 2013; 28(1):6-15. PubMed ID: 23808425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemoprevention of photocarcinogenesis by lycopene.
    Ascenso A; Ribeiro H; Marques HC; Oliveira H; Santos C; Simões S
    Exp Dermatol; 2014 Dec; 23(12):874-8. PubMed ID: 25040310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemopreventive effects of natural dietary compounds on cancer development.
    Pan MH; Ho CT
    Chem Soc Rev; 2008 Nov; 37(11):2558-74. PubMed ID: 18949126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response of hormone refractory prostate cancer to lycopene.
    Matlaga BR; Hall MC; Stindt D; Torti FM
    J Urol; 2001 Aug; 166(2):613. PubMed ID: 11458084
    [No Abstract]   [Full Text] [Related]  

  • 33. Can tomatoes fight oral cancer?
    J Am Dent Assoc; 2001 Feb; 132(2):154, 156. PubMed ID: 11217586
    [No Abstract]   [Full Text] [Related]  

  • 34. Lycopene for advanced hormone refractory prostate cancer: a prospective, open phase II pilot study.
    Schwenke C; Ubrig B; Thürmann P; Eggersmann C; Roth S
    J Urol; 2009 Mar; 181(3):1098-103. PubMed ID: 19150092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronicles in drug discovery.
    Moral MA; Khurdayan VK; Bozzo J
    Drug News Perspect; 2006 Oct; 19(8):485-9. PubMed ID: 17160149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tomatoes or lycopene versus prostate cancer: is evolution anti-reductionist?
    Gann PH; Khachik F
    J Natl Cancer Inst; 2003 Nov; 95(21):1563-5. PubMed ID: 14600081
    [No Abstract]   [Full Text] [Related]  

  • 37. Agents used for chemoprevention of prostate cancer may influence PSA secretion independently of cell growth in the LNCaP model of human prostate cancer progression.
    Peternac D; Klima I; Cecchini MG; Schwaninger R; Studer UE; Thalmann GN
    Prostate; 2008 Sep; 68(12):1307-18. PubMed ID: 18512728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Participation of lycopene and beta-carotene in carcinogenesis: defenders, aggressors, or passive bystanders?
    Arab L; Steck-Scott S; Bowen P
    Epidemiol Rev; 2001; 23(2):211-30. PubMed ID: 12192734
    [No Abstract]   [Full Text] [Related]  

  • 39. Is there a benefit from lycopene supplementation in men with prostate cancer? A systematic review.
    Haseen F; Cantwell MM; O'Sullivan JM; Murray LJ
    Prostate Cancer Prostatic Dis; 2009; 12(4):325-32. PubMed ID: 19901932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lycopene's Effects on Cancer Cell Functions within Monolayer and Spheroid Cultures.
    Holzapfel NP; Holzapfel BM; Theodoropoulos C; Kaemmerer E; Rausch T; Feldthusen J; Champ S; Clements JA; Hutmacher DW; Loessner D
    Nutr Cancer; 2016; 68(2):350-63. PubMed ID: 27015041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.